RRIG1 expression was inversely correlated with lymph node metastasis of breast cancer but was not associated with the status of hormone receptors, such as estrogen receptor, progesterone receptor, or HER2. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.